Moolec Science (Moolec Science) Cash-to-Debt : 0.22 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Moolec Science Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Moolec Science's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.22.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Moolec Science couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Moolec Science's Cash-to-Debt or its related term are showing as below:

MLEC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.22 Med: 38.88 Max: No Debt
Current: 0.22

During the past 3 years, Moolec Science's highest Cash to Debt Ratio was No Debt. The lowest was 0.22. And the median was 38.88.

MLEC's Cash-to-Debt is ranked worse than
91.55% of 1492 companies
in the Biotechnology industry
Industry Median: 6.85 vs MLEC: 0.22

Moolec Science Cash-to-Debt Historical Data

The historical data trend for Moolec Science's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Moolec Science Cash-to-Debt Chart

Moolec Science Annual Data

Trend

Jun21

Jun22

Jun23

Cash-to-Debt

No Debt

1.07

Moolec Science Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial					65.18	38.88	1.07	0.31	0.22

Competitive Comparison of Moolec Science's Cash-to-Debt

For the Biotechnology subindustry, Moolec Science's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moolec Science's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Moolec Science's Cash-to-Debt falls into.

Moolec Science Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Moolec Science's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.834	/	(2.546	+	0.099)
	=	1.07

Moolec Science's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.834	/	(2.39	+	5.945)
	=	0.22

Moolec Science (NAS:MLEC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Moolec Science Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Moolec Science's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Moolec Science (Moolec Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411

Website

https://www.moolecscience.com

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system.